title: Expression of c-myc, c-raf-1, and c-Ki-ras in azaserine-induced pancreatic carcinomas and growing pancreas in rats.
abstract: We examined the pattern of expression of several proto-oncogenes during nonneoplastic growth and in acinar cell neoplasms in the rat pancreas. The levels of c-myc, c-raf-1, and c-Ki-ras mRNAs were increased in regenerating pancreata following surgical partial pancreatectomy and following administration of camostat. We also investigated proto-oncogene expression associated with the progression of pancreatic cancers in azaserine-treated rats. Injection of a single dose (30 mg/kg) of azaserine (O-diazoacetyl-L-serine) to 14-d-old rats leads to a variety of neoplastic lesions in the rat pancreas. Total RNA was isolated from lesions in various stages of tumor progression, including adenomas, carcinomas in situ, and invasive carcinomas. We observed increased expression of c-myc, c-raf-1, and c-Ki-ras in azaserine-induced adenomas and carcinomas. Actin expression was also increased in these tissues, whereas amylase expression was variable. However, when compared to the normal growing pancreas, the level of proto-oncogene expression in the adenomas and carcinomas was disproportionate to the degree of cellular division in those tissues. Thus, the alterations induced by azaserine apparently caused a deregulated increase in expression of cellular oncogenes associated with growth regulation.
authors.affiliation: Department of Pathology, Dartmouth Medical School, Hanover, New Hampshire 03756.
authors.forename: J A
authors.initials: JA
authors.lastname: Silverman
authors.forename: E T
authors.initials: ET
authors.lastname: Kuhlmann
authors.forename: J
authors.initials: J
authors.lastname: Zurlo
authors.forename: J D
authors.initials: JD
authors.lastname: Yager
authors.forename: D S
authors.initials: DS
authors.lastname: Longnecker
mesh_terms: D000236:Adenoma / Q000235:genetics; D000818:Animals; D001377:Azaserine / Q000494:pharmacology*; D015152:Blotting, Northern; D002277:Carcinoma / Q000235:genetics; D002453:Cell Cycle; D004952:Esters; D016670:Gabexate / Q000031:analogs & derivatives*; D015870:Gene Expression; D006146:Guanidines / Q000494:pharmacology; D008940:Mitotic Index; D010179:Pancreas / Q000502:physiology*; D010190:Pancreatic Neoplasms / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics*; D019908:Proto-Oncogene Proteins c-raf; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics*; D011519:Proto-Oncogenes; D012334:RNA, Neoplasm / Q000235:genetics; D051381:Rats; D011917:Rats, Inbred Lew; D012038:Regeneration
chemical_list: D004952:Esters; D006146:Guanidines; D011518:Proto-Oncogene Proteins; D016271:Proto-Oncogene Proteins c-myc; D012334:RNA, Neoplasm; C034532:camostat; D016670:Gabexate; D001377:Azaserine; D019908:Proto-Oncogene Proteins c-raf; D016283:Proto-Oncogene Proteins p21(ras)